131 related articles for article (PubMed ID: 31496778)
21. Linagliptin versus glimepiride add-on for the long-term treatment of Type 2 diabetes mellitus.
Chilton R
Expert Rev Endocrinol Metab; 2013 Jul; 8(4):345-349. PubMed ID: 30736150
[TBL] [Abstract][Full Text] [Related]
22. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
Jyoti U; Kansal SK; Kumar P; Goyal S
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
[TBL] [Abstract][Full Text] [Related]
23. Endothelium-dependent relaxation to acetylcholine in bovine oviductal arteries: mediation by nitric oxide and changes in apamin-sensitive K+ conductance.
García-Pascual A; Labadía A; Jimenez E; Costa G
Br J Pharmacol; 1995 Aug; 115(7):1221-30. PubMed ID: 7582549
[TBL] [Abstract][Full Text] [Related]
24. Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.
Raffetto JD; Yu P; Reslan OM; Xia Y; Khalil RA
J Vasc Surg; 2012 Jun; 55(6):1716-25. PubMed ID: 22209615
[TBL] [Abstract][Full Text] [Related]
25. Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery.
Leo CH; Joshi A; Woodman OL
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H502-11. PubMed ID: 20543087
[TBL] [Abstract][Full Text] [Related]
26. Endothelial mediators of the acetylcholine-induced relaxation of the rat femoral artery.
Leung HS; Leung FP; Yao X; Ko WH; Chen ZY; Vanhoutte PM; Huang Y
Vascul Pharmacol; 2006 May; 44(5):299-308. PubMed ID: 16527547
[TBL] [Abstract][Full Text] [Related]
27. Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension.
Barnett AH; Patel S; Harper R; Toorawa R; Thiemann S; von Eynatten M; Woerle HJ
Diabetes Obes Metab; 2012 Dec; 14(12):1145-54. PubMed ID: 22974280
[TBL] [Abstract][Full Text] [Related]
28. Roles of calcium-activated and voltage-gated delayed rectifier potassium channels in endothelium-dependent vasorelaxation of the rabbit middle cerebral artery.
Dong H; Waldron GJ; Cole WC; Triggle CR
Br J Pharmacol; 1998 Mar; 123(5):821-32. PubMed ID: 9535009
[TBL] [Abstract][Full Text] [Related]
29. DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes-Induced Blood-Brain Barrier Leakage and Normalize Capillary Pericyte Coverage.
Elabi OF; Karampatsi D; Vercalsteren E; Lietzau G; Nyström T; Klein T; Darsalia V; Patrone C; Paul G
Diabetes; 2023 Mar; 72(3):405-414. PubMed ID: 36448982
[TBL] [Abstract][Full Text] [Related]
30. Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes.
Hardigan T; Abdul Y; Ergul A
Life Sci; 2016 Aug; 159():90-96. PubMed ID: 26898123
[TBL] [Abstract][Full Text] [Related]
31. DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice.
Ma M; Hasegawa Y; Koibuchi N; Toyama K; Uekawa K; Nakagawa T; Lin B; Kim-Mitsuyama S
Cardiovasc Diabetol; 2015 May; 14():54. PubMed ID: 25986579
[TBL] [Abstract][Full Text] [Related]
32. Contribution of nitric oxide, cyclic GMP and K+ channels to acetylcholine-induced dilatation of rat conduit and resistance arteries.
Woodman OL; Wongsawatkul O; Sobey CG
Clin Exp Pharmacol Physiol; 2000; 27(1-2):34-40. PubMed ID: 10696526
[TBL] [Abstract][Full Text] [Related]
33. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
Plane F; Wiley KE; Jeremy JY; Cohen RA; Garland CJ
Br J Pharmacol; 1998 Apr; 123(7):1351-8. PubMed ID: 9579730
[TBL] [Abstract][Full Text] [Related]
34. Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions.
Allen T; Iftinca M; Cole WC; Plane F
J Physiol; 2002 Dec; 545(3):975-86. PubMed ID: 12482900
[TBL] [Abstract][Full Text] [Related]
35. Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2016 Apr; 79():16-23. PubMed ID: 26277250
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic characteristics of non-prostanoid, non-nitric oxide mediated and endothelium-dependent relaxation of guinea-pig aorta in response to substance P.
Tanaka Y; Kaneko H; Tanaka H; Shigenobu K
Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):65-81. PubMed ID: 10440572
[TBL] [Abstract][Full Text] [Related]
37. Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor.
Capettini LS; Cortes SF; Gomes MA; Silva GA; Pesquero JL; Lopes MJ; Teixeira MM; Lemos VS
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2503-11. PubMed ID: 18952716
[TBL] [Abstract][Full Text] [Related]
38. Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet.
Giardina JB; Green GM; Rinewalt AN; Granger JP; Khalil RA
Hypertension; 2001 Feb; 37(2 Pt 2):516-23. PubMed ID: 11230328
[TBL] [Abstract][Full Text] [Related]
39. Glycyrrhetinic acid-sensitive mechanism does not make a major contribution to non-prostanoid, non-nitric oxide mediated endothelium-dependent relaxation of rat mesenteric artery in response to acetylcholine.
Tanaka Y; Otsuka A; Tanaka H; Shigenobu K
Res Commun Mol Pathol Pharmacol; 1999 Mar; 103(3):227-39. PubMed ID: 10509734
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.
Zhang Y; Liu J; Tian XY; Wong WT; Chen Y; Wang L; Luo J; Cheang WS; Lau CW; Kwan KM; Wang N; Yao X; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):152-9. PubMed ID: 24202302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
